Using blood flow restriction to speed recovery after heavy resistance exercise

Effect of Blood Flow Restriction on Recovery After Maximal Resistance Exercise: a Controlled Clinical Trial

Not applicable Interventional Paulista University · NCT07342634

This trial will test whether short sessions of blood flow restriction at different pressures help healthy men and women recover faster after intense resistance workouts.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment80 (estimated)
Ages18 Years to 35 Years
SexAll
SponsorPaulista University Academic / other
Locations1 site (Presidente Prudente, São Paulo)
Trial IDNCT07342634 on ClinicalTrials.gov

What this trial studies

This randomized clinical trial will enroll 80 healthy adults (40 men, 40 women) who will be assigned to one of four groups receiving blood flow restriction at 80% of total occlusion pressure, 60% of total occlusion pressure, a low-pressure sham (10 mmHg), or a control condition. All participants will complete a standardized maximal resistance exercise protocol, have baseline and post-exercise assessments, receive their assigned recovery intervention, and then be reassessed immediately and at 24, 48, and 72 hours. Outcomes include pain ratings, perceived recovery and effort scales, bioelectrical impedance markers, pressure-pain thresholds, myotonometry measures of muscle tone/stiffness/elasticity, quadriceps strength, and jump performance tests. The design compares different BFR pressures to determine whether and which pressure accelerates recovery of symptoms and function after muscle-stressing exercise.

Who should consider this trial

Good fit: Ideal candidates are healthy adults who perform vigorous resistance exercise and do not have diabetes, hypertension, inflammatory or cardiovascular/respiratory disease, thromboembolism risk factors, or injuries that limit high-intensity activity.

Not a fit: People with diabetes, hypertension, inflammatory or cardiovascular/respiratory disease, thromboembolic risk factors, existing exercise-limiting injuries, or those unable to attend in-person testing are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, this approach could shorten soreness and speed return to full performance after intense resistance sessions, helping athletes and active adults resume training sooner.

How similar studies have performed: Several small randomized studies and meta-analyses have reported that blood flow restriction can reduce post-exercise soreness and aid recovery, but optimal pressures and standardized protocols remain uncertain.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals exhibiting one or more of the following characteristics will not be included:
* (1) diabetes and hypertension;
* (2) inflammatory rheumatological, psychiatric, cardiovascular and/or respiratory disease;
* (3) pre-existing injury restricting their ability to perform vigorous physical activities;
* (4) having one or more predisposing risk factors for thromboembolism.

Exclusion Criteria:

* Participants will be excluded from the study if they:
* (1) have a health problem that does not allow them to continue;
* (2) wish to leave the study;
* (3) use medications, electrotherapy, or other therapeutic methods during the study period that could interfere with any results;
* (4) not sign the consent form.

Where this trial is running

Presidente Prudente, São Paulo

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions RecoveryRecovery TimeResistance trainingphysiological stresspost-exercise recoveryblood flow restriction therapyfunctional physical performance
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.